Xenopus laevis oocytes provide an efficient translation system for microinjected, beterologous mRNAs. They offer several advantages over conventional in vitro translation systems since oocytes can perform postranslational processes such as proteolytic cleavage, glycosylation, sequestration, and secretion of products (1-3). Translation products have been detected in whole oocyte extracts and secretory proteins have been found in the culture medium of the oocytes (4-7). The acetylcholine receptor, an integral membrane protein, was found associated with a membrane fraction of oocyte extracts (4). Oocyte translation products have been detected by their biologic activity (6), enzymatic activity (8), and by biosynthetic labeling with radioactive precursors followed by immunoprecipitation (4, 7). We are interested in the expression of Fc receptors and their genetic organization. Fc receptors (FcR) are a group of plasma membrane proteins that bind the Fc domain of immunoglobulin (Ig). These receptors are expressed by many cells of the immune system (9), are in many instances inducible (10), and differ in their specificity for different isotypes of Ig. We report here that translated mammalian plasma membrane receptors can be detected by binding of labeled ligands or monoclonal anti-receptor antibodies on the oocyte plasma membrane. This assay affords a sensitive and rapid method for the detection of rare mRNA species that code for plasma membrane proteins.
Isolation of mRNA. RNA was isolated by extraction with guanidine thiocyanate (14) from cells grown in spinner culture. Poly(A) + mRNA was selected by affinity chromatography on oligo-dT cellulose.
Xenopus Oocyte Assays. Isolated oocytes (15) were incubated for 2 h at room temperature with gentle agitation in Ca++-free OR-2 saline containing 2 mg/ml collagenase (Type 1A; Sigma Chemical Co., St. Louis, MO) and were then rinsed with half-strength L-15 medium (Gibco Laboratories, Grand Island, NY) supplemented with 100 U/ml of penicillin, 5/~g/ml of gentamycin, and 10 mM Hepes, pH 7.4. The oocytes were injected with 60 nl of mRNA (usually 1 mg/ml) in water and incubated for 2 d in half strength L-15.
For binding assays, the oocytes were incubated for 1 h at room temperature in medium containing ~2~I-ligand (1 #g/ml, 104 cpm/ng protein) and [14C]sucrose (0.67 mM sucrose, 3.7 mCi/mmole; New England Nuclear, Boston, MA). After washing, oocytes showing intact animal/vegetal pole morphology were individually assayed for l~sI in a gamma counter, and the oocytes were then prepared for scintillation counting by the addition of 0.1 ml of 0.5 M NH~OH and 2 ml of Hydroflour (New England Nuclear). The high end of the 14C spectrum was assayed, and the results corrected for 1% spillover of 12~I into the 14C channel. Oocytes that took up more [~4C]sucrose than the mean plus 3 SD incorporated by control oocytes were considered nonviable, and were disregarded. Binding of ligand was scored as positive if the amount of ~SI-ligand bound was >3 SD above the mean bound by controls. The stimulation index was calculated as: experimental cpm bound/average control cpm bound. mRNA from the Fcv2b/~lR-positive cell line bound 125I-2.4G2 Fab specifically ( Fig. 1 ). Those oocytes injected with mRNA from L5178Y (an FcR-negative T cell line) that bound 125I-2.4G2 Fab also took up [14C]sucrose, demonstrating that these oocytes were nonviable and that uptake of iigand was thus nonspecific. Binding of ~5I-2.4G2 Fab was detected after the injection of as little as 120 pg of mRNA per oocyte and was dependent on the amount of mRNA injected ( Fig.  2A) . The percentage of oocytes binding ~25I-2.4G2 Fab over background levels reached a plateau at 70% with 6 ng of injected mRNA (data not shown), and the amount of receptor per oocyte generally began to plateau at 30-60 ng of mRNA ( Fig. 2A) . Receptor expression was detectable 24 h after injection and increased until day 3 (Fig. 2B) . The binding of 125I-2.4G2 Fab was inhibited by the presence of an excess of unlabeled 2.4G2 Fab (data not shown). We investigated whether radiolabeled monoclonal antibodies specific for J774 cell surface proteins other than FcR were bound by oocytes injected with J774 mRNA. J25I-2E2A, a monocional IgG directed against a major 82,000 Mr plasma membrane protein (12) found on J774 cells (6 × 105 sites per cell), binds to oocytes injected with J774 mRNA. The percentage of oocytes binding 125I-2.4G2 Fab and 125I-2E2A over background levels was 80 and 65%, respectively. The average stimulation index was 5.4 + 3.2 for 125I-2E2A Fab and 20 + 11 for 125I-2.4G2 Fab. These data indicate that binding of monoclonal antibodies to oocyte plasma membranes is likely to be a general method for the study of cell surface components.
Results a n d Discussion

Expression of Murine
Expression of Functional Rat Fc~R on Oocytes. We next investigated the applicability of the oocyte system to translation of other Fc receptors for which we had no monoclonal antibody probe. The RBL-1 rat basophilic leukemia line (2H3 subline) expresses a high avidity receptor for IgE (Fc,R) (16) . Individual oocytes injected with RBL-1 mRNA bound as much as 22,000 cpm of 125I-IR-162 rat IgE, compared with an average of 215 _+ 36 cpm bound to water-injected oocytes ( Fig. 3A and B) . Comparable data were obtained with a mouse IgE hybridoma (13) (data not shown), indicating that the Fc,R bound the IgE by the Fc domain and not the antigen-combining site. Furthermore, as might be predicted by the absence of high avidity Fc~R on J774 cells, ~25I-rat IgE did not Table I) . We prepared mRNA from untreated and y-IFN-treated U937 cells for injection into oocytes. The oocytes were able to express functional human Fc~Rhi, as demonstrated by binding of lu~I-IgG2a to oocytes injected with mRNA from y-IFNtreated U937 cells (Table I and Fig. 3 C) . Remarkably, the density per #m 2 of FcsRhi is comparable on the y-IFN-induced U937 cells and the oocytes injected with mRNA isolated from these cells ( Table I ). The binding of 1 t~g/ml of lusIIgG2a was inhibited 60% by 2 t~g/ml of unlabeled IgG2a, but not by the F(ab')2 fragment (Fig. 3, D and E) . However, 10-fold less binding of l~sI-IgG2a was observed on oocytes injected with mRNA from untreated U937 cells compared with y-IFN-treated U937 cells (Table I) U937 cells grown in spinner (3-4 x 105 cells/ml) were treated with 100 U/ml of recombinant y-IFN. Cells were assayed or mRNA prepared after 18 h. Binding studies on U937 cells were performed at 25°C as described (17) using iodinated IgG2a mouse myeloma protein LPC-1 (1 ~g/ml; 8 x l0 s cpm/ng). Oocytes injected with mRNA were
also assayed for binding of I-LPC-1. In reticulocyte lysates, both mRNA preparations catalyzed the synthesis of high Mr proteins, indicating that the mRNA preparations were of good quality. in the oocyte membrane. Many monoclonal antibodies (including 2.4G2 IgG) do not immunoprecipitate reticulocyte lysate translation products. Since the Fc,2b/ ~tR message is rare, it is difficult to immunoprecipitate FC~b/,1R from [3~S]-methionine-labeled oocyte lysates. The screen for ligand or monoclonal antibody binding to the oocyte surface is a rapid and sensitive assay for minor mRNA species, and the method promises to be of great utility for the molecular analysis of membrane receptors by both their ligand binding and antigenic properties.
Summary
We report that Xenopus laevis oocytes can efficiently translate and insert heterologous membrane receptors into the oocyte plasma membrane, where they can be detected by the binding of either monoclonal antibodies or ligands. Thus, oocytes injected with mRNA from the mouse J774 macrophage-like cell line, the rat RBL-1 basophilic leukemia, and the U937 promonocyte cell line, bound 2.4G2 Fab, rat IgE, and mouse IgG2a, respectively. The increase in the high avidity Fc,R observed after 3,-interferon induction of U937 cells was also observed after injection of mRNA from 3,-interferon-induced U937 cells into oocytes. This suggests either much greater message stability or a greater rate of transcription of Fc~Rhi mRNA in the 3,-interferon-induced cells. The assay affords a sensitive method for the detection of rare mRNA species that code for plasma membrane proteins.
